Search



Search only items with full text availability
Current filters:

Clear current filters  or Add more filters

View Option



Results 21-30 of 573 (Search time: 0.003 seconds).

  Effects of combination of orlistat and micronised fenofibrate on lipid profile in overweight and obese patients with metabolic syndrome (Journal article)

  Autoantibody titers against OxLDL are correlated with achilles tendon thickness in patients with familial hypercholesterolemia (Journal article)

  The effects of orlistat and fenofibrate, alone or in combination, on high-density lipoprotein subfractions and pre-beta1-HDL levels in obese patients with metabolic syndrome (Journal article)

  THE EFFECTS OF COMBINING ROSUVASTATIN WITH SARTANS OF DIFFERENT PPAR gamma ACTIVATING CAPACITY ON LOW-DENSITY LIPOPROTEIN SUBFRACTIONS AND LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A(2) (Journal article)

  Dose-dependent Effect of Rosuvastatin Treatment on HDL-subfraction Phenotype in Patients With Primary Hyperlipidemia (Journal article)

  Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed Dyslipidaemia (Journal article)

  Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure (Journal article)

  Emerging cardiovascular risk factors in subclinical hypothyroidism: lack of change after restoration of euthyroidism (Journal article)

  Combining Rosuvastatin with Sartans of Different Peroxisome Proliferator-Activated Receptor-gamma Activating Capacity Is Not Associated with Different Changes in Low-Density Lipoprotein Subfractions and Plasma Lipoprotein-Associated Phospholipase A(2) (Journal article)

  The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemia (Journal article)